Vaxcell-Bio Therapeutics Stock Forecast - Day Median Price
323990 Stock | KRW 11,170 600.00 5.68% |
Vaxcell-Bio Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Vaxcell-Bio Therapeutics stock prices and determine the direction of Vaxcell Bio Therapeutics Co's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Vaxcell-Bio Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Vaxcell-Bio |
Previous Day Median Price | Day Median Price | Trend |
12650.0 | 12695.0 |
Check Vaxcell-Bio Therapeutics Volatility | Backtest Vaxcell-Bio Therapeutics | Trend Details |
Vaxcell-Bio Therapeutics Trading Date Momentum
On November 28 2024 Vaxcell Bio Therapeutics Co was traded for 12,950 at the closing time. The highest price during the trading period was 13,480 and the lowest recorded bid was listed for 12,710 . The volume for the day was 126.6 K. This history from November 28, 2024 contributed to the next trading day price jump. The daily price change to the next closing price was 1.09% . The trading price change to the current price is 5.15% . |
The median price is the midpoint of the trading periods range.
Compare Vaxcell-Bio Therapeutics to competition |
Other Forecasting Options for Vaxcell-Bio Therapeutics
For every potential investor in Vaxcell-Bio, whether a beginner or expert, Vaxcell-Bio Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Vaxcell-Bio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Vaxcell-Bio. Basic forecasting techniques help filter out the noise by identifying Vaxcell-Bio Therapeutics' price trends.Vaxcell-Bio Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vaxcell-Bio Therapeutics stock to make a market-neutral strategy. Peer analysis of Vaxcell-Bio Therapeutics could also be used in its relative valuation, which is a method of valuing Vaxcell-Bio Therapeutics by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Vaxcell-Bio Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Vaxcell-Bio Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Vaxcell-Bio Therapeutics' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Vaxcell-Bio Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Vaxcell-Bio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaxcell-Bio Therapeutics shares will generate the highest return on investment. By undertsting and applying Vaxcell-Bio Therapeutics stock market strength indicators, traders can identify Vaxcell Bio Therapeutics Co entry and exit signals to maximize returns.
Accumulation Distribution | 4727.07 | |||
Daily Balance Of Power | 0.9524 | |||
Rate Of Daily Change | 1.06 | |||
Day Median Price | 10925.0 | |||
Day Typical Price | 11006.67 | |||
Market Facilitation Index | 0.0075 | |||
Price Action Indicator | 545.0 | |||
Period Momentum Indicator | 600.0 | |||
Relative Strength Index | 54.39 |
Vaxcell-Bio Therapeutics Risk Indicators
The analysis of Vaxcell-Bio Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Vaxcell-Bio Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting vaxcell-bio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 1.92 | |||
Standard Deviation | 2.53 | |||
Variance | 6.4 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Vaxcell-Bio Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxcell-Bio Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcell-Bio Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Vaxcell-Bio Stock
Moving against Vaxcell-Bio Stock
The ability to find closely correlated positions to Vaxcell-Bio Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxcell-Bio Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxcell-Bio Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxcell Bio Therapeutics Co to buy it.
The correlation of Vaxcell-Bio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxcell-Bio Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxcell-Bio Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxcell-Bio Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vaxcell-Bio Stock
Vaxcell-Bio Therapeutics financial ratios help investors to determine whether Vaxcell-Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vaxcell-Bio with respect to the benefits of owning Vaxcell-Bio Therapeutics security.